Rheumatoid Arthritis–Associated Interstitial Lung Disease: Current Update on Prevalence, Risk Factors, and Pharmacologic Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rheumatoid Arthritis–Associated Interstitial Lung Disease: Current Update on Prevalence, Risk Factors, and Pharmacologic Treatment

Published:2020-09-01 Issue:4 Volume:6 Page:337-353
ISSN:2198-6002
Container-title:Current Treatment Options in Rheumatology
language:en
Short-container-title:Curr Treat Options in Rheum

Author:

Huang Sicong,Kronzer Vanessa L.,Dellaripa Paul F.,Deane Kevin D.,Bolster Marcy B.,Nagaraja Vivek,Khanna Dinesh,Doyle Tracy J.,Sparks Jeffrey A.

Funder

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Institutes of Health

Rheumatology Research Foundation

R. Bruce and Joan M. Mickey Research Scholar Fund

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s40674-020-00160-z.pdf

Reference100 articles.

1. Yoshida K, Lin TC, Wei M, Malspeis S, Chu SH, Camargo CA, et al. The roles of post-diagnosis accumulation of morbidities and lifestyle changes on excess total and cause-specific mortality risk in rheumatoid arthritis. Arthritis care res (Hoboken). 2019. https://doi.org/10.1002/acr.24120.A large study with lengthy follow-up demonstrating accumulation of morbidities and excess respiratory mortality for patients with seropositive RA.

2. Sparks JA, Chang SC, Liao KP, Lu B, Fine AR, Solomon DH, et al. Rheumatoid arthritis and mortality among women during 36 years of prospective follow-up: results from the nurses’ health study. Arthritis Care Res (Hoboken). 2016;68(6):753–62. https://doi.org/10.1002/acr.22752.

3. England BR, Sayles H, Michaud K, Caplan L, Davis LA, Cannon GW, et al. Cause-specific mortality in male US veterans with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2016;68(1):36–45. https://doi.org/10.1002/acr.22642.

4. Bongartz T, Nannini C, Medina-Velasquez YF, Achenbach SJ, Crowson CS, Ryu JH, et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2010;62(6):1583–91. https://doi.org/10.1002/art.27405.

5. •• Hyldgaard C, Hilberg O, Pedersen AB, Ulrichsen SP, Lokke A, Bendstrup E, et al. A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality. Ann Rheum Dis. 2017;76(10):1700–6. https://doi.org/10.1136/annrheumdis-2017-211138.A large nationwide study investigating incidence and prevalance of RA-ILD in relation to RA onset.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analyzing how SiMiao Wan regulates ferroptosis to prevent RA-ILD using metabolomics and cyberpharmacology;Phytomedicine;2024-10

2. Effect of abatacept versus conventional synthetic disease modifying anti-rheumatic drugs on rheumatoid arthritis-associated interstitial lung disease;The Korean Journal of Internal Medicine;2024-09-01

3. A Systematic Review of the Key Predictors of Progression and Mortality of Rheumatoid Arthritis-Associated Interstitial Lung Disease;Diagnostics;2024-08-28

4. Abatacept versus tumor necrosis factor inhibitors on mortality and medical utilizations in the treatment of rheumatoid arthritis associated interstitial lung disease: a large-scale real-world retrospective cohort study;Clinical and Experimental Medicine;2024-08-12

5. Exploring rheumatoid arthritis associated interstitial lung disease a retrospective study from two Saudi tertiary care centers;BMC Rheumatology;2024-08-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3